(Karolinska Institutet) A thyroid-hormone-like substance that works specifically on the liver reduces blood cholesterol with no serious side effects. This according to a clinical trial conducted by researchers from the Swedish medical university Karolinska Institutet, amongst other centers, published today in the top-ranking scientific periodical the New England Journal of Medicine.
Read »Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Medicine
- An Ensemble Classifier for Eukaryotic Protein Subcellular Location Prediction Using Gene Ontology Categories and Amino Acid Hydr
- UBC researchers discover key to immune cell's 'internal guidance' system
- Children hospitalized at alarming rate due to abuse
- Coronavirus Papain-like Proteases Negatively Regulate Antiviral Innate Immune Response through Disruption of STING-Mediated Sign
- Lewis Weintraub, MD, honored for excellence